FDA Approves First-of-its-Kind Glaucoma Treatment
https://www.brightfocus.org/glaucoma/news/fda-approves-first-its-kind-glaucoma-treatment
webDec 15, 2023 · The U.S. Food and Drug Administration has approved a new treatment for glaucoma, iDose® TR (travoprost intracameral implant, 75 mcg). iDose TR is a first-of-its kind treatment that is designed to provide up to three years of 24/7, continuous drug therapy directly inside the eye, helping people with glaucoma take control over the elevated eye …
DA: 34 PA: 7 MOZ Rank: 76